Christopher Martell - 29 Jul 2021 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ John Canepa, Attorney-in-Fact
Issuer symbol
CADL
Transactions as of
29 Jul 2021
Net transactions value
+$1,000,000
Form type
4
Filing time
02 Aug 2021, 20:12:23 UTC
Previous filing
26 Jul 2021
Next filing
17 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Conversion of derivative security +283,514 283,514 29 Jul 2021 By GTAM1 2012 ADV LLC F1, F2
transaction CADL Common Stock Purchase $1,000,000 +125,000 $8.00* 125,000 29 Jul 2021 By GTAM1 2012 LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Series B Preferred Stock Conversion of derivative security $0 -696,851 -100% $0.000000* 0 29 Jul 2021 Common Stock 283,514 By GTAM1 2012 ADV LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.
F2 Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
F3 Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

Remarks:

Exhibit 24 - Power of Attorney